These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17696794)

  • 1. Rufinamide: a new anti-epileptic medication.
    Hakimian S; Cheng-Hakimian A; Anderson GD; Miller JW
    Expert Opin Pharmacother; 2007 Aug; 8(12):1931-40. PubMed ID: 17696794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome.
    Wisniewski CS
    Ann Pharmacother; 2010 Apr; 44(4):658-67. PubMed ID: 20233912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice.
    Striano P; McMurray R; Santamarina E; Falip M
    Epileptic Disord; 2018 Feb; 20(1):13-29. PubMed ID: 29313492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rufinamide: Pharmacology, clinical trials, and role in clinical practice.
    Cheng-Hakimian A; Anderson GD; Miller JW
    Int J Clin Pract; 2006 Nov; 60(11):1497-501. PubMed ID: 17073844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview.
    Wier HA; Cerna A; So TY
    Paediatr Drugs; 2011 Apr; 13(2):97-106. PubMed ID: 21351809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rufinamide. An orphan drug for treatment of Lennox-Gastaut syndrome].
    Kreutzkamp B
    Med Monatsschr Pharm; 2007 Oct; 30(10):358-61. PubMed ID: 17966284
    [No Abstract]   [Full Text] [Related]  

  • 7. Rufinamide.
    Heaney D; Walker MC
    Drugs Today (Barc); 2007 Jul; 43(7):455-60. PubMed ID: 17728846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rufinamide: a new antiepileptic drug treatment for Lennox-Gastaut syndrome.
    Ferrie CD
    Expert Rev Neurother; 2010 Jun; 10(6):851-60. PubMed ID: 20518600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines.
    Coppola G; Besag F; Cusmai R; Dulac O; Kluger G; Moavero R; Nabbout R; Nikanorova M; Pisani F; Verrotti A; von Stülpnagel C; Curatolo P
    Eur J Paediatr Neurol; 2014 Nov; 18(6):685-90. PubMed ID: 24929673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rufinamide: CGP 33101, E 2080, RUF 331, Xilep.
    Drugs R D; 2005; 6(4):249-52. PubMed ID: 15991887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of epilepsy: newly approved and developmental agents.
    Stephen LJ; Brodie MJ
    CNS Drugs; 2011 Feb; 25(2):89-107. PubMed ID: 21254787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rufinamide.
    Deeks ED; Scott LJ
    CNS Drugs; 2006; 20(9):751-60; discussion 761. PubMed ID: 16953653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rufinamide. A review of its pharmacokinetic and pharmacodynamic properties].
    Herranz JL
    Rev Neurol; 2008 Oct 1-15; 47(7):369-73. PubMed ID: 18841549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan.
    Ohtsuka Y; Yoshinaga H; Shirasaka Y; Takayama R; Takano H; Iyoda K
    Epilepsy Res; 2014 Nov; 108(9):1627-36. PubMed ID: 25219353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
    Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
    Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome.
    Glauser T; Kluger G; Sachdeo R; Krauss G; Perdomo C; Arroyo S
    Neurology; 2008 May; 70(21):1950-8. PubMed ID: 18401024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of rufinamide as adjunctive therapy in patients with Lennox Gastaut syndrome: A systematic review and Meta-analysis.
    Sharawat IK; Panda PK; Panda P; Dawman L
    Seizure; 2021 Oct; 91():296-307. PubMed ID: 34273668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosing considerations for rufinamide in patients with Lennox-Gastaut syndrome: Phase III trial results and real-world clinical data.
    Kothare S; Kluger G; Sachdeo R; Williams B; Olhaye O; Perdomo C; Bibbiani F
    Seizure; 2017 Apr; 47():25-33. PubMed ID: 28284045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness and safety of rufinamide at treatment of epilepsy with complications and drug-resistant epilepsy (according to meta-analysis data)].
    Mazin PV; Sheshunov IV; Kislitsyn YV; Mazina NK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8):40-43. PubMed ID: 27635610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.